Endpoints News 2026년 3월 9일 GSK licenses linerixibat for liver disease itch to Alfasigma for $300M upfront
Endpoints News 2026년 3월 7일 UniQure’s dispute with FDA; Zealand’s obesity readout; China takes on world’s most expensive medicines; and more
Endpoints News 2026년 3월 6일 Pfizer gets obesity drug approval in China shortly after buying local rights
Endpoints News 2026년 3월 6일 Lilly plucks Flagship, bluebird vet for regenerative medicine unit; Novo's new China president
Endpoints News 2026년 3월 5일 Helus Pharma's stock slides after psychedelic drug data face questions over dosing